Literature DB >> 8263770

Vascular pharmacodynamics of NG-nitro-L-arginine methyl ester in vitro and in vivo.

Y X Wang1, C I Poon, C C Pang.   

Abstract

The inhibitory effects of NG-nitro-L-arginine methyl ester (L-NAME) on endothelium-dependent vasodilatation were studied in conscious rats and isolated rat aortic rings. In phenylephrine (PE, ED90)-preconstricted aortae, L-NAME caused prolonged and complete inhibition of acetylcholine (ACh)-induced relaxation with IC50 of 4 x 10(-7) M and Hill coefficient (n) of 1. The inhibition was abolished by L-arginine (L-Arg), independently of whether it was applied 10 min earlier or 4 hr later than L-NAME. Intravenous bolus injection of L-NAME caused prolonged increases in mean arterial pressure (MAP), with Emax of 50 +/- 7 mm Hg, ED50 of 5 +/- 1 x 10(-6) mol/kg and n of 2. Intravenous infusion of L-Arg shifted the dose-MAP curve of L-NAME to the right without changing Emax or n. A modified Schild plot (n = 2) for the action of L-NAME gave a slope not different from unity, suggesting that L-Arg inhibits competitively the MAP response of L-NAME. Intravenous infusion of ACh decreased MAP in rats treated with L-NAME (4.8 x 10(-5) mol/kg) or PE. Compared to PE-treated rats, L-NAME inhibited the depressor response to ACh by 50%. Thus, a dose of L-NAME 10 times its ED50 in raising MAP only partially blocked the depressor responses to ACh.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263770

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

Review 1.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

2.  Morroniside, a secoiridoid glycoside from Cornus officinalis, attenuates neuropathic pain by activation of spinal glucagon-like peptide-1 receptors.

Authors:  Meng Xu; Hai-Yun Wu; Hao Liu; Nian Gong; Yi-Rui Wang; Yong-Xiang Wang
Journal:  Br J Pharmacol       Date:  2017-02-16       Impact factor: 8.739

3.  Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats.

Authors:  F J Dowell; D Henrion; M Duriez; J B Michel
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

4.  Sensitivity of arterial spin labeling perfusion MRI to pharmacologically induced perfusion changes in rat kidneys.

Authors:  Huan Tan; Jon Thacker; Tammy Franklin; Pottumarthi V Prasad
Journal:  J Magn Reson Imaging       Date:  2014-05-06       Impact factor: 4.813

5.  Sensitivity of USPIO-enhanced R2 imaging to dynamic blood volume changes in the rat kidney.

Authors:  Pippa Storey; Lin Ji; Lu-Ping Li; Pottumarthi V Prasad
Journal:  J Magn Reson Imaging       Date:  2011-05       Impact factor: 4.813

6.  Increase by NG-nitro-L-arginine methyl ester (L-NAME) of resistance to venous return in rats.

Authors:  Y X Wang; S L Lim; C C Pang
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  Vascular pharmacology of methylene blue in vitro and in vivo: a comparison with NG-nitro-L-arginine and diphenyleneiodonium.

Authors:  Y X Wang; X Cheng; C C Pang
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

8.  BOLD quantified renal pO2 is sensitive to pharmacological challenges in rats.

Authors:  Jon Thacker; Jeff L Zhang; Tammy Franklin; Pottumarthi Prasad
Journal:  Magn Reson Med       Date:  2016-08-08       Impact factor: 4.668

9.  Nitric oxide release accounts for insulin's vascular effects in humans.

Authors:  U Scherrer; D Randin; P Vollenweider; L Vollenweider; P Nicod
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

10.  Endogenous inotropic factor-induced endothelium-dependent relaxation of vascular smooth muscle.

Authors:  C Han; J C Khatter
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.